Your browser doesn't support javascript.
loading
Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.
Renz, Bernhard W; Tanaka, Takayuki; Sunagawa, Masaki; Takahashi, Ryota; Jiang, Zhengyu; Macchini, Marina; Dantes, Zahra; Valenti, Giovanni; White, Ruth A; Middelhoff, Moritz A; Ilmer, Matthias; Oberstein, Paul E; Angele, Martin K; Deng, Huan; Hayakawa, Yoku; Westphalen, C Benedikt; Werner, Jens; Remotti, Helen; Reichert, Maximilian; Tailor, Yagnesh H; Nagar, Karan; Friedman, Richard A; Iuga, Alina C; Olive, Kenneth P; Wang, Timothy C.
Afiliação
  • Renz BW; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tanaka T; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Sunagawa M; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Takahashi R; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto, Nagasaki, Japan.
  • Jiang Z; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Macchini M; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Dantes Z; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Valenti G; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • White RA; Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Middelhoff MA; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
  • Ilmer M; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Oberstein PE; Division of Oncology, Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Angele MK; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Deng H; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hayakawa Y; Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York.
  • Westphalen CB; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Werner J; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Remotti H; Department of Pathology, and Molecular Medicine and Genetics Center, The Fourth Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Reichert M; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Tailor YH; Department of Gastroenterology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
  • Nagar K; Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Friedman RA; Department of Internal Medicine III, Hospital of the University of Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Iuga AC; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Olive KP; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York.
  • Wang TC; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
Cancer Discov ; 8(11): 1458-1473, 2018 11.
Article em En | MEDLINE | ID: mdl-30185628
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Células-Tronco Neoplásicas / Transformação Celular Neoplásica / Colinérgicos / Carcinoma Ductal Pancreático / Receptor Muscarínico M1 Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Células-Tronco Neoplásicas / Transformação Celular Neoplásica / Colinérgicos / Carcinoma Ductal Pancreático / Receptor Muscarínico M1 Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha